Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

100.34 +2.19 (+2.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Start Of The Week
British property (real estate) stocks fell today. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Inari Medical (NASDAQ:NARI) stock... 
Via Benzinga
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
From Agendia, Inc.
Via Business Wire
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
From GRAIL, LLC
Via Business Wire
Early Cancer Detection for Dogs Is Here
SOURCE: Illumina 
Via 3BL Media
Illumina Selected As a Best Place to Work in Biopharma
SOURCE: Illumina 
Via 3BL Media
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
Illumina Donates Over $14 Million to Local Communities and Volunteers More Than 6,000 Hours in 2021
SOURCE: Illumina 
Via 3BL Media
Why Jim Cramer Likes Illumina And Enterprise Products Partners
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
Illumina Enters Co-Development Partnership with SomaLogic to Help Researchers’ Understanding of Biology and Disease
SOURCE: Illumina 
Via 3BL Media
Illumina CEO Reflects on the State of Genomics in 2021
SOURCE: Illumina 
Via 3BL Media
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Illumina Supports Norway's Pioneering Precision Medicine Study
SOURCE: Illumina 
Via 3BL Media
Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research
From Gretel
Via Business Wire
Amid Pandemic, Illumina Invests in 'Culture of Care'
SOURCE: Illumina 
Via 3BL Media
Topics Supply Chain
Why Jim Cramer Likes Illumina, SoFi And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ: 
Via Benzinga
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
Illumina Ranked #2 on Newsweek's America's Most Responsible Companies 2022 List
SOURCE: Illumina 
Via 3BL Media
Illumina and Sequoia Capital China Select First Startups to Join Genomics Incubator in China
SOURCE: Illumina 
Via 3BL Media
Bionano Genomics Proves Not Everything Genetic is Gold
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes. 
Via InvestorPlace
10x Genomics Stock: Bull vs. Bear
After a hot start, the stock has recently lagged the market. Is now a good time to buy? 
Via The Motley Fool
Topics Initial Public Offering
Wait for Bionano Stock to Fall Further Before Buying
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term. 
Via InvestorPlace
Proteomics Market Worth $55.9 Billion by 2026 - Size, Share, Developments, Opportunities, Key Players Analysis
Northbrook, IL -- (SBWIRE) -- 11/22/2021 -- Proteomics Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future. 
Via SBWire
Illumina's Shanghai Employees and Families Help Conserve Wetland Reserve
SOURCE: Illumina 
Via 3BL Media
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Major Statistics & Growth Dynamics
Northbrook, IL -- (SBWIRE) -- 11/19/2021 -- Single-cell Analysis Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future. 
Via SBWire
Following Rough Year, Is Burning Rock Set To Turn The Corner?
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s... 
Via Benzinga
Europe To Layout Objections to Illumina-Grail Deal: Bloomberg
Illumina Inc (NASDAQ: ILMN) says the European Union will issue a list of objections tomorrow over the Company's $8B takeover of GRAIL, Bloomberg reports. Related... 
Via Benzinga
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
SOURCE: Illumina 
Via 3BL Media
Topics Religion
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.